pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Vir Biotechnology appoints David Liu as chief medical officer

Oct 30, 2026·read at STAT ↗Neutral

Vir Biotechnology announced the hiring of David Liu as its new chief medical officer.

Liu joins the company after serving as chief medical officer at Nuvation Bio, where he held the same position.

The addition expands Vir’s senior leadership team as it continues to develop its pipeline and address ongoing challenges in the pharmaceutical sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Up and down the ladder: The latest comings and goings”

read at STAT ↗
469 words · retrieved 23m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY2NUVATION2Nuvation Bio Inc.2ASTRAZENECARISING
topics
Obesity

related stories

  • Oct 14‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma banBioSpace
  • Oct 75 biggest venture capital raises of Q3 2026BioSpace
  • Jul 2STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreSTAT
  • May 6Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive
  • Jun 9Gilead and Merck’s latest trial success and flopSTAT